Thyroid Cancer Antibodies

Thyroid cancer is the most common thyroid malignant tumor, it is a malignant tumor derived from thyroid epithelial cells, accounting for about 1% of all malignant tumors. The majority of thyroid cancers originate from follicular epithelial cells and can be divided into papillary carcinoma, follicular carcinoma, undifferentiated carcinoma and medullary carcinoma according to pathological types. Papillary carcinoma with low malignancy and good prognosis is the most common. Follicular adenocarcinoma tumor growth faster, is a moderate malignant, easy to transhemal metastasis; Undifferentiated carcinomas have a poor prognosis, with an average survival time of 3 to 6 months.

Elabscience^® high quality thyroid cancer-related antibodies will help you to accurately determine the expression of relevant important indicators in the first place.

View All the Thyroid Cancer Antibodies>>